Press Releases

Press Releases

    Date Title View
    04/27/22
    Summary ToggleHorizon Therapeutics plc Among Top Companies for Overall Corporate Reputation in 2021 Global PatientView Survey of Patient Groups Worldwide
    PDF Version
    04/19/22
    Summary ToggleHorizon Therapeutics and Massachusetts Institute of Technology (MIT) Solve Announce Second Annual Horizon Prize to Inspire Solutions that Improve the Quality of Life for the Global Rare Disease Community
    PDF Version
    04/14/22
    Summary ToggleHorizon Therapeutics plc to Release First-Quarter 2022 Financial Results and Host Webcast on May 4, 2022
    PDF Version
    04/11/22
    Summary ToggleHorizon Therapeutics plc Named One of the Fortune 100 Best Companies to Work For®
    PDF Version
    03/31/22
    Summary ToggleNew Analysis Finds UPLIZNA® (inebilizumab-cdon) Effective for People with Newly-Presenting Neuromyelitis Optica Spectrum Disorder (NMOSD)
    PDF Version
    03/24/22
    Summary ToggleHorizon Therapeutics plc Named as One of the Best Workplaces in Ireland
    PDF Version
    03/07/22
    Summary ToggleHorizon Therapeutics plc Announces FDA Has Granted Priority Review of the Supplemental Biologics License Application (sBLA) for the Concomitant Use of KRYSTEXXA® (pegloticase injection) Plus Methotrexate for People Living With Uncontrolled Gout
    PDF Version
    03/02/22
    Summary ToggleHorizon Therapeutics plc Partners with Christine Ha, First Blind Contestant and Winner of MasterChef, to Amplify Her Unstoppable NMOSD Story
    PDF Version
    03/01/22
    Summary ToggleHorizon Therapeutics plc Reports Fourth-Quarter 2021 and Full-Year 2021 Financial Results; Announces Full-Year 2022 Guidance
    02/28/22
    Summary ToggleHorizon Therapeutics plc Launches #RAREis Representation Program to Elevate Global Rare Disease Equity
    PDF Version
    Displaying 11 - 20 of 655 results